Natural killer cells mediate pathophysiology in response to reduced uterine perfusion pressure

Clinical Science

Volumn 131, Issue 23, 2017, Pages 2753-2762

  Elfarra, Jamil ^a   Amaral, Lorena M ^a   McCalmon, Maggie ^a   Scott, Jeremy D ^a   Cunningham, Mark W ^a   Gnam, Ashley ^a   Ibrahim, Tarek ^a   LaMarca, Babbette ^a   Cornelius, Denise C ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GAMMA INTERFERON; GANGLIOTETRAOSYLCERAMIDE; TUMOR NECROSIS FACTOR; AUTACOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; ELEVATED BLOOD PRESSURE; FEMALE; FETUS WEIGHT; FLOW CYTOMETRY; HYPERTENSION; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; INTRAUTERINE PRESSURE; ISCHEMIA; MEAN ARTERIAL PRESSURE; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PERFUSION PRESSURE; PLACENTA WEIGHT; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RAT; REDUCED UTERINE PERFUSION PRESSURE; T CELL DEPLETION; ANIMAL; BLOOD; BLOOD PRESSURE; CYTOTOXICITY; FETUS; METABOLISM; PATHOLOGY; PERFUSION; PLACENTA; SPRAGUE DAWLEY RAT; UTERUS;

ANIMALS; BLOOD PRESSURE; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FETAL GROWTH RETARDATION; FETUS; HYPERTENSION; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; ISCHEMIA; KILLER CELLS, NATURAL; PERFUSION; PLACENTA; PREGNANCY; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; UTERUS;

EID: 85035762625     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20171118     Document Type: Article

References (35)

1. American College of O, Gynecologists, Task Force on Hypertension in P. Hypertension in pregnancy (2013) Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet. Gynecol. 122, 1122-1131
2. Dekker, G.A. and Sibai, B.M. (1998) Etiology and pathogenesis of preeclampsia: current concepts. Am. J. Obstet. Gynecol. 179, 1359-1375
3. Cudihy, D. and Lee, R.V. (2009) The pathophysiology of pre-eclampsia: current clinical concepts. J. Obstet. Gynaecol. 29, 576-582
4. Cornelius, D.C. and Lamarca, B. (2014) TH17-and IL-17-mediated autoantibodies and placental oxidative stress play a role in the pathophysiology of pre-eclampsia. Minerva Ginecol. 66, 243-249
5. Palei, A.C., Spradley, F.T., Warrington, J.P., George, E.M. and Granger, J.P. (2013) Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta. Physiol. (Oxf.) 208, 224-233
6. Fukui, A., Funamizu, A., Yokota, M., Yamada, K., Nakamua, R., Fukuhara, R. et al. (2011) Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy loss, implantation failure and preeclampsia. J. Reprod. Immunol. 90, 105-110
7. Fukui, A., Yokota, M., Funamizu, A., Nakamua, R., Fukuhara, R., Yamada, K. et al. (2012) Changes of NK cells in preeclampsia. Am. J. Reprod. Immunol. 67, 278-286
8. Saito, S., Shiozaki, A., Sasaki, Y., Nakashima, A., Shima, T. and Ito, M. (2007) Regulatory T cells and regulatory natural killer (NK) cells play important roles in feto-maternal tolerance. Semin. Immunopathol. 29, 115-122
9. Saito, S., Nakashima, A., Myojo-Higuma, S. and Shiozaki, A. (2008) The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy. J. Reprod. Immunol. 77, 14-22
10. Karimi, K. and Arck, P.C. (2010) Natural killer cells: keepers of pregnancy in the turnstile of the environment. Brain Behav. Immun. 24, 339-347
11. Vacca, P., Moretta, L., Moretta, A. and Mingari, M.C. (2011) Origin, phenotype and function of human natural killer cells in pregnancy. Trends Immunol. 32, 517-523
12. Arck, P.C. and Hecher, K. (2013) Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nat. Med. 19, 548-556
13. Farag, S.S. and Caligiuri, M.A. (2006) Human natural killer cell development and biology. Blood Rev. 20, 123-137
14. Inngjerdingen, M., Kveberg, L., Naper, C. and Vaage, J.T. (2011) Natural killer cell subsets in man and rodents. Tissue Antigens 78, 81-88
15. Peritt, D., Robertson, S., Gri, G., Showe, L., Aste-Amezaga, M. and Trinchieri, G. (1998) Cutting edge: differentiation of human NK cells into NK1 and NK2 subsets. J. Immunol. 161, 5821-5824
16. Al Omar, S., Flanagan, B.F., Almehmadi, M. and Christmas, S.E. (2013) The effects of IL-17 upon human natural killer cells. Cytokine 62, 123-130
17. Giezeman-Smits, K.M., Gorter, A., Nagelkerke, J.F., van Vlierberghe, R.L., van Eendenburg, J., Eggermont, A.M. et al. (1997) Characterization of three new membrane structures on rat NK cells which are involved in activation of the lytic machinery. Immunobiology 197, 429-443
18. Luo, D.Z., Vermijlen, D., Ahishali, B., Triantis, V., Vanderkerken, K., Kuppen, P.J. et al. (2000) Participation of CD45, NKR-P1A and ANK61 antigen in rat hepatic NK cell (pit cell)mediated target cell cytotoxicity. World J. Gastroenterol. 6, 546-552
19. Wedel, J., Hottenrott, M.C., Bulthuis, M., Huitema, S., Yard, B.A. and Hillebrands, J.L. (2016) N-octanoyl dopamine attenuates the development of transplant vasculopathy in rat aortic allografts via smooth muscle cell protective mechanisms. Transplantation 100, 80-90
20. Wu, J., Zhou, C., Robertson, J., Carlock, C. and Lou, Y.H. (2014) Peripheral blood CD8alphaalpha+CD11c+MHC-II+CD3-cells attenuate autoimmune glomerulonephritis in rats. Kidney Int. 85, 1078-1090
21. Altomonte, J., Marozin, S., De Toni, E.N., Rizzani, A., Esposito, I., Steiger, K. et al. (2013) Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis. Mol. Ther. 21, 2032-2042
22. Giezeman-Smits, K.M., Jonges, L.E., Chambers, W.H., Brisette-Storkus, C.S., Van Vlierberghe, R.L., Van Eendenburg, J.D. et al. (1998) Novel monoclonal antibodies against membrane structures that are preferentially expressed on IL-2-activated rat NK cells. J. Leukoc. Biol. 63, 209-215
23. Granger, J.P., LaMarca, B.B., Cockrell, K., Sedeek, M., Balzi, C., Chandler, D. et al. (2006) Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol. Med. 122, 383-392
24. LaMarca, B., Wallace, K., Herse, F., Wallukat, G., Martin, Jr, J.N., Weimer, A. et al. (2011) Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes. Hypertension 57, 865-871
25. Alexander, B.T., Kassab, S.E., Miller, M.T., Abram, S.R., Reckelhoff, J.F., Bennett, W.A. et al. (2001) Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 37, 1191-1195
26. Murphy, S.P., Fast, L.D., Hanna, N.N. and Sharma, S. (2005) Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice. J. Immunol. 175, 4084-4090
27. Chakraborty, D., Rumi, M.A., Konno, T. and Soares, M.J. (2011) Natural killer cells direct hemochorial placentation by regulating hypoxia-inducible factor dependent trophoblast lineage decisions. Proc. Natl. Acad. Sci. U.S.A. 108, 16295-16300
28. Monnier, J. and Zabel, B.A. (2014) Anti-asialo GM1 NK cell depleting antibody does not alter the development of bleomycin induced pulmonary fibrosis. PLoS One 9, e99350
29. Toldi, G., Rigo, Jr, J., Stenczer, B., Vasarhelyi, B. and Molvarec, A. (2011) Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am. J. Reprod. Immunol. 66, 223-229
30. Small, H.Y., Nosalski, R., Morgan, H., Beattie, E., Guzik, T.J., Graham, D. et al. (2016) Role of tumor necrosis factor-alpha and natural killer cells in uterine artery function and pregnancy outcome in the stroke-prone spontaneously hypertensive rat. Hypertension 68, 1298-1307
31. LaMarca, B.B., Bennett, W.A., Alexander, B.T., Cockrell, K. and Granger, J.P. (2005) Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension 46, 1022-1025
32. Marsden, P.A. and Brenner, B.M. (1992) Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am. J. Physiol. 262, C854-C861
33. LaMarca, B., Speed, J., Fournier, L., Babcock, S.A., Berry, H., Cockrell, K. et al. (2008) Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension 52, 1161-1167
34. Cornelius, D.C., Hogg, J.P., Scott, J., Wallace, K., Herse, F., Moseley, J. et al. (2013) Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension 62, 1068-1073
35. Cornelius, D.C., Amaral, L.M., Wallace, K., Campbell, N., Thomas, A.J., Scott, J. et al. (2016) Reduced uterine perfusion pressure T-helper 17 cells cause pathophysiology associated with preeclampsia during pregnancy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 311, R1192-R1199